BioLife Plasma Services leases 12,000 s/f at Blumenfeld’s The Crossings retail center

Bronx, NY The Blumenfeld Development Group (BDG) said that BioLife Plasma Services, part of the Takeda Pharmaceutical Company, has signed an 11-year lease becoming the most recent tenant at The Crossings retail center.

The 12,000 s/f facility is scheduled to open in the first quarter of 2025. BioLife Plasma Services is an industry leader in the collection of plasma that is processed into life-saving plasma-based therapies. They operate plasma collection facilities throughout the United States and Europe.

“We are excited that BioLife has chosen The Crossings as their newest location in New York,” said Brad Blumenfeld, principal, Blumenfeld Development Group. “Having an industry leader choose this specific location shows their commitment to operating their first-class operation at a top rate facility.”

The Crossings, a 40,000 s/f retail space in the South Bronx, is located at the corner of Southern Blvd. and Hunts Point Ave. and was BDG’s first endeavor in the borough.

Since opening in the fall of 2017, the Crossings has served the community with a variety of tenants across industry and sector including McDonalds, Dollar Tree, Dunkin Donuts, and Optimum Mobile among others.

BioLife was represented by Trent Dickey of JLL.

Tags: Brokerage

Reprint

Previous Story Next Story

REALM, DelShah Capital and A.M. Properties acquire 377,000 s/f CitySpire office condominium

Manhattan, NY REALM, in partnership with DelShah Capital and A.M. Properties, acquired CitySpire, a 377,000 s/f office condominium comprising 24 floors within the 70-story tower at 156 W 56th St. in Midtown.

Atlantic Capital Partners sells 893 Bdwy. 25,442 s/f office/retail building for $31 million

Atlantic Cap. Ptrs. sells 893 Bdwy. 25,442 s/f office/retail bldg. - $31m

Koeppel Rosen closes 18,200 s/f lease expansion/extension with Fenwick & West at 902 Bdwy.

SL Green Realty signs Kohlberg to 18,820 s/f at 500 Park Ave.

Houlihan Lawrence Commercial sells 1,600 s/f retail - $735,000

READ ON THE GO

DIGITAL EDITIONS

Browse Now

Quick Hits

Spotlight Content

2026 Ones to Watch - Rising Stars: Hugo Donath, North Bridge

Columns and Thought Leadership

The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

July 1, 2025 is the deadline for US banks to begin to adopt Basel III banking standards and July 14, 2025 is the deadline for U.S. banks to adopt ISO 20022 messaging standards. Both will have a significant effect on the banking and commercial real estate (CRE) finance sectors.

A fresh start - by Shallini Mehra and Amit Doshi

For the past several years, the New York City multifamily housing market has been defined by disruption. The combined impact of the HSTPA rent laws and a sharply higher interest rate environment has fundamentally reduced

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

There was a time when an offering memorandum (OM) was pretty bare bones, some photos, a few bullet points on income, and a rent roll thrown in at the back. That used to get the job done. Not anymore. In 2025, buyers are sharper, faster, and more selective. They’re looking

Tri-state capital migrates nationally amid regulation pressure - by Reese Weaver

New York tri-state multifamily investors are increasingly reallocating capital to less-regulated markets across the U.S. as rent control and legislative risk erode returns at home. With over 60% of New York City’s rental housing stock classified as rent-stabilized, the traditional value-add model — buying under-performing buildings,